No data to show
OTCM
SONX
Market cap491kUSD
Jun 25, Last price
1.15USD
Name
Sonendo Inc
Chart & Performance
P/E
—
P/S
0.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
91.47%
Rev. gr., 5y
-1.81%
Revenues
32m
-27.73%
Net income
-28m
L-53.98%
CFO
-25m
L-46.48%
Profile
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 31,702 -27.73% | 43,865 5.30% | 41,656 25.48% | |||
Cost of revenue | 61,068 | 45,498 | 47,952 | |||
Unusual Expense (Income) | ||||||
NOPBT | (29,366) | (1,633) | (6,296) | |||
NOPBT Margin | ||||||
Operating Taxes | 2 | 2 | 2 | |||
Tax Rate | ||||||
NOPAT | (29,368) | (1,635) | (6,298) | |||
Net income | (28,033) -53.98% | (60,919) 6.78% | (57,050) 17.63% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 127 | 20,516 | ||||
BB yield | -0.64% | -16.13% | ||||
| Debt | ||||||
Debt current | 11,885 | 26,316 | 1,114 | |||
Long-term debt | 5,421 | 17,019 | 40,050 | |||
Deferred revenue | 302 | |||||
Other long-term liabilities | 3,967 | 83 | 773 | |||
Net debt | 5,679 | (3,447) | (50,285) | |||
| Cash flow | ||||||
Cash from operating activities | (24,652) | (46,062) | (61,072) | |||
CAPEX | (161) | (929) | (1,356) | |||
Cash from investing activities | 45,814 | 42,402 | (74,429) | |||
Cash from financing activities | (24,945) | 4 | 68,525 | |||
FCF | (27,779) | 4,684 | (20,015) | |||
| Balance | ||||||
Cash | 11,627 | 46,782 | 91,449 | |||
Long term investments | ||||||
Excess cash | 10,042 | 44,589 | 89,366 | |||
Stockholders' equity | (458,046) | (429,938) | (369,105) | |||
Invested Capital | 481,257 | 499,167 | 490,788 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 474,856 | 93,989 | 44,933 | |||
Price | 1.81 761.90% | 0.21 -92.58% | 2.83 -50.87% | |||
Market cap | 859,489 4,254.57% | 19,738 -84.48% | 127,160 287.67% | |||
EV | 865,168 | 16,291 | 76,875 | |||
EBITDA | (29,027) | 1,342 | (3,480) | |||
EV/EBITDA | 12.14 | |||||
Interest | 5,471 | 3,174 | 3,228 | |||
Interest/NOPBT | ||||||